Skip to main content

Symptomatic Heart Failure

Case-based content highlighting recommendations for chronic medical management

Start Date: April 24, 2018
Duration: ~45 minutes
Price: $35

Course Description

In this course, Dr. Anju Nohria, cardiologist and subspecialist in advanced heart failure at Brigham and Women’s Hospital and Harvard Medical School, provides a comprehensive update on the diagnosis and management patients with acute heart failure (HF), with expert insights on the optimal treatments for individual patients.

In her presentation, Dr. Nohria discusses the benefits and complications of revascularization in the treatment of HF, recent data on use of ACE inhibitors and beta blockers in HF, and reviews the risks and benefits of ICD therapy. In addition, she outlines staging factors that guide medical therapy in heart failure patients and she discuses how to educate patients about the risks and benefits of new and alternative medicines as well as nonpharmacological options and beneficial lifestyle changes.

This course is intended for primary care and internal medicine physicians and others interested in learning more about recognizing and treating patients with symptomatic heart failure.

Dr. Nohria's presentation can also be found in our comprehensive internal medicine and board review course, Update and Board Review in Internal Medicine: Part One.

What You'll Learn

  • Determine current management of heart failure
  • Review recent landmark studies in the area
  • Recognize the role of advanced therapies in the care of heart failure patients


Anju Nohria, MD

Anju Nohria, MD Assistant Professor of Medicine, Harvard Medical School; Associate Physician, Cardiovascular Division, Brigham and Women's Hospital


Symptomatic Heart Failure is organized as follows:

Precourse Information:
Accreditation and AMA Credit Designation
Disclosure Statement
How to Take This Course
Viewing Videos
Grading and Certificates

Management of Acute Decompensated Heart Failure
Case Introduction
Pharmacologic Treatments
Nonpharmacologic Treatments
Case Conclusion

CME Certificate
CME Posttest
Course Evaluation



The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


The Harvard Medical School designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Policy

Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education, course planners, speakers, and content reviewers have been asked to disclose any relevant relationship they, or their spouse or partner, have to companies producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and participants with information that might be of potential importance to their evaluation of a given presentation.

Disclosure Statement

The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing health care goods or services (relevant to the content of the activity) consumed by, or used on, patients:

Name: Anju Nohria, MD
Role: Course Faculty
Company: Vertex Pharmaceuticals
Relationship: Consultant

All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.


Dr. Martina M. McGrath, MB, BCh, FASN is an instructor in medicine at Harvard Medical School. She is also an associate physician and attending nephrologist at Brigham and Women’s Hospital.

Dr. McGrath completed her medical degree, internal medicine residency, and nephrology training in Ireland. She then completed the Brigham and Women’s Hospital/Massachusetts General Hospital Nephrology fellowship program and joined faculty at BWH and HMS in 2012.

Her subspecialty interest is in transplant nephrology, and she is an investigator in basic transplant immunology, based at the Transplantation Research Center, BWH. Her research is focused on targeting T cell costimulatory pathways in allograft rejection, and developing novel therapies to target these pathways and promote the development of regulatory T cells and allograft tolerance. She also is active in the area of medical education, serving as course director for the combined BWH/HMS Update in Internal Medicine series of courses.

View Dr. McGrath's profile.


How long will this course take?

This course should take approximately 45 minutes to complete. You do not need to complete it all at once. You may come back as often as you like.

How long will this course be available?

This self-paced course will close enrollments one year after its start date.

What web browser should I use?

The platform works best with current versions of Chrome, Firefox, or Safari, or with Internet Explorer version 11 and above. See our list of supported browsers for the most up-to-date information.

What if I want to learn more about this topic?

HMS Continuing Education holds live topic-focused conferences throughout the year. Please see our course catalog for upcoming events.